Hungarian Biotech Database

SEOUL, South Korea, June 16, 2020 /PRNewswire/ -- Medit announces the nomination of its new Chief Executive Officer, GB (Gyu Bum) Ko, amidst the company's 20(th) year as a global provider of 3D scanning solutions. Ko joins Medit to accelerate its growth strategy as a leader in the dental... Read more ››

By: PR Newswire Association LLC. - 16 Jun 2020

Sanofi to present growth opportunities and development strategy for Dupixent® (dupilumab) in type 2 inflammatory diseases

By: GlobenewsWire - 11 Jun 2020

Innovent and Roche Enter into A Strategic Collaboration to Discover and Develop Multiple Products including Cellular Therapies and Bispecific Antibodies

SUZHOU, China, June 8, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announced... Read more ››

By: PR Newswire Association LLC. - 09 Jun 2020

1 2 3 4 »

Looking for companies outside of Hungary?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

August 2020
- ChinaBio® Partnering Forum 2020 Digital
- Biotechgate Digital Partnering Event
September 2020
- Basel: Pharma-Biotech Product & Company Valuation

See Events »

Add an Event »

Latest company news

Sanofi and GSK in advanced discussions with European Union to supply up to 300 million doses of COVID-19 vaccine
31 Jul 2020 (GlobenewsWire)

Sanofi and GSK selected for Operation Warp Speed to supply United States government with 100 million doses of COVID-19 vaccine
31 Jul 2020 (GlobenewsWire)

Nirsevimab reduced respiratory syncytial virus infections requiring medical care in healthy premature infants in Phase 2b trial
30 Jul 2020 (GlobenewsWire)

News in the Life Sciences Industry

Sanofi and GSK in advanced discussions with European Union to supply up to 300 million doses of COVID-19 vaccine

Sanofi and GSK selected for Operation Warp Speed to supply United States government with 100 million doses of COVID-19 vaccine

Nirsevimab reduced respiratory syncytial virus infections requiring medical care in healthy premature infants in Phase 2b trial

Online availability of Sanofi’s half-year financial report for 2020

Sanofi H1 2020 business EPS(1) growth of 9.2%(2) driven by transformation

Sanofi and GSK agree with the UK government to supply up to 60 million doses of COVID-19 vaccine

Sanofi: Information concerning the total number of voting rights and shares - June 2020

Availability of the Pre-quarterly Results Communication

Sanofi and Regeneron provide update on Kevzara® (sarilumab) Phase 3 U.S. trial in COVID-19 patients

Sanofi’s virtual R&D Day event to highlight capabilities, platforms, and expertise in disease pathways to deliver potentially transformative treatments to patients

Sanofi: Information concerning the total number of voting rights and shares - May 2020

Sanofi announces positive long-term efficacy and safety data for fitusiran from interim analysis of Phase 2 extension study in people with hemophilia A and B, with or without inhibitors

Sanofi’s investigational enzyme replacement therapy shows clinically meaningful improvement in critical manifestations of late-onset Pompe disease

Sanofi invests to make France its world class center of excellence in vaccine research and production

Medit Celebrates 20th Anniversary and Appoints GB (Gyu Bum) Ko as New CEO to Accelerate Growth Strategy

Sanofi to present growth opportunities and development strategy for Dupixent® (dupilumab) in type 2 inflammatory diseases

Innovent and Roche Enter into A Strategic Collaboration to Discover and Develop Multiple Products including Cellular Therapies and Bispecific Antibodies

Sanofi to present Phase 3 results of avalglucosidase alfa in patients with late-onset Pompe disease

Sanofi to launch “Action 2020”, a worldwide employee stock purchase plan

European Commission approves Sarclisa® (isatuximab) for adults with relapsed and refractory multiple myeloma

Looking for companies outside of Hungary?

Partners

Upcoming Life Sciences Events

Latest company news